Dear Sir/Madam, Pursuant to Regulation 57(5) of SEBI(Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached intimation for the quarter ended on 31st December, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has filed a quarterly compliance intimation with BSE and MSEI under SEBI LODR Regulation 57(5) for the quarter ended 31st December 2025. The company has confirmed that it has not issued any non-convertible securities (NCS). Consequently, there were no interest, dividend, or principal repayment obligations due during 1st October 2025 to 31st December 2025. The letter is signed by Director Davender Singh and dated 2nd January 2026.
This is a routine nil-compliance filing and has no material impact on the stock or shareholders. It simply confirms the company has no listed non-convertible debt obligations to report on for the quarter.